SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-22-006598
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:43
Documents
15
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K endra_8k.htm   iXBRL 8-K 23613
2 PRESS RELEASE DATED MAY 12, 2022, FURNISHED HEREWITH. endra_ex991.htm EX-99.1 148349
  Complete submission text file 0001654954-22-006598.txt   312419

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ndra-20220512.xsd EX-101.SCH 5845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ndra-20220512_lab.xml EX-101.LAB 15313
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ndra-20220512_cal.xml EX-101.CAL 908
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ndra-20220512_pre.xml EX-101.PRE 9750
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ndra-20220512_def.xml EX-101.DEF 2113
9 EXTRACTED XBRL INSTANCE DOCUMENT endra_8k_htm.xml XML 3716
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 22917784
SIC: 3845 Electromedical & Electrotherapeutic Apparatus